Skip to content

Quantitative evaluation of the effect of partial splenic artery embolization on hepatic reserve function by HVPG and ICG excretion tests

Quantitative evaluation of the effect of partial splenic artery embolization on hepatic reserve function by HVPG and ICG excretion tests

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076703
Enrollment
Unknown
Registered
2023-10-16
Start date
2023-10-20
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

Treatment Group (Single arm):partial splenic embolization (PSE)

Sponsors

Yibin Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Clinically diagnosed patients with post-hepatitis or alcoholic cirrhosis decompensated stage; 2) accompanied by laboratory findings or clinical symptoms and signs related to hypersplenism; 3) It may be combined with esophageal and gastric varices or a history of venous gastrointestinal bleeding; 4) The Child-Pugh score of liver function was A/B grade; 5) No portal vein thrombosis; 6) No diabetes, cardiopulmonary insufficiency and other serious organ diseases; 7) Good clinical compliance.

Exclusion criteria

Exclusion criteria: 1) Other specific types of cirrhosis; 2) Liver function Child-Pugh grade C; 3) Cirrhosis with primary or secondary malignant tumors of the liver; 4) Portal vein system stenosis or occlusion; 5) Formation of portal vein thrombosis or cancer thrombus; 6) Natural gastrorenal or spleno-renal shunt; 7) History of chronic hypertension, diabetes or pancreatitis; 8) Serious dysfunction of heart, liver, kidney and other organs; 9) Have blood system diseases; 10) Previous history of endoscopic treatment for esophageal and gastric varices, interventional treatment of liver and spleen and surgical operations; 11) History of abdominal trauma; 12) Combined with medium to large amounts of ascites or refractory ascites; 13) Spontaneous peritonitis, etc.

Design outcomes

Primary

MeasureTime frame
HVPG measure;ICG R15 Retention rate;

Secondary

MeasureTime frame
Child-Pugh fractionation;QLQ-C30 mark;

Countries

China

Contacts

Public ContactZhu Jun

Yibin Second People's Hospital

865149749@qq.com+86 831 822 3013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026